“…All cells were routinely screened in the lab for the expression of the following markers: CD29, CD31 (negative), CD34 (negative), CD44, CD45 (negative), CD73, CD90, CD105, as described previously. [ 23 ] Their MSC properties were investigated by the following experiments: - Colony‐forming unit assay: hPDLSCs of 4 × 10 3 per well were inoculated in six‐well plates with 2 mL culture medium changed every 2 d. After 3 weeks, the cells were fixed with 4% PFA for 20 min and stained with 1% crystal violet for 1 h. The cell colonies consisting of more than 50 cells were observed using light microscopy (Primo Vert, Carl Zeiss, Jena, Germany).
- Cell‐doubling time assay: hPDLSCs of 5 × 10 5 per well were inoculated in T175 culture flasks with 20 mL culture medium changed every 2 d. After 3, 6, 9, and 12 d, the cells were collected and counted to produce a cell‐growth curve.
- Cell viability assay: hPDLSCs of 5 × 10 3 per well were inoculated in 96‐well plates with 0.1 mL culture medium changed every 2 d. After 1, 3, 5, and 7 d, the cell viability was longitudinally assessed by AlamarBlue HS Cell Viability Reagent as described before. [ 56 ]
- Osteogenic differentiation assay: hPDLSCs of 8 × 10 3 per well were inoculated in 24‐well plates with 0.5 mL culture medium.
…”